Apogee Therapeutics Inc (APGE)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subc... Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. Show more
Ask ADVFN Intelligence (AI)
SAN FRANCISCO and WALTHAM, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for...
Pharmacokinetic data up to 9 months continue to support potential best-in-class profile, including a half-life of approximately 75 days, approximately three to five times that of currently...
SAN FRANCISCO and WALTHAM, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for...
SAN FRANCISCO and WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 6.9 | 12.7259313906 | 54.22 | 62.23 | 52.37 | 520562 | 58.56554229 | CS |
| 4 | 4.78 | 8.48420305289 | 56.34 | 62.23 | 50.48 | 345665 | 55.70236259 | CS |
| 12 | 15.68 | 34.5070422535 | 45.44 | 62.23 | 45.28 | 396162 | 53.90460185 | CS |
| 26 | 5.84 | 10.5643994211 | 55.28 | 62.23 | 36.26 | 436095 | 48.42728823 | CS |
| 52 | 46.21 | 309.926224011 | 14.91 | 72.29 | 14.91 | 469473 | 48.35818748 | CS |
| 156 | 39.62 | 184.279069767 | 21.5 | 72.29 | 14.19 | 436176 | 42.85239164 | CS |
| 260 | 39.62 | 184.279069767 | 21.5 | 72.29 | 14.19 | 436176 | 42.85239164 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
